Logistic回归分析糖尿病肾病发生的影响因素
摘要
关键词
全文:
PDF参考
[1]Li Y, Liu Y, Liu S, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies[J] Signal Transduct Target Ther. 2023,8(01):152-181.
[2]Tomkins M, Lawless S, Martin-Grace J, et al. Diagnosis and Management of Central Diabetes Insipidus in Adults. J Clin Endocrinol Metab. 2022,107(10):2701-2715.
[3]赵群,王文绢.2型糖尿病血管并发症危险因素控制研究进展[J].中国慢性病预防与控制,2022,30(04):302-306.
[4]Goldney J,Sargeant JA,Davies MJ. Incretins and microvascular complications of diabetes: neuropathy,nephropathy,retinopathy and microangiopathy[J].Diabetologia. 2023,66(10):1832-1845
[5]Selby NM, Taal MW. An updated overview of diabetic nephropathy: Diagnosis, prognosis,treatment goals and latest guidelines[J]. Diabetes Obes Metab. 2020,2(01):3-15.
[6]An Y,Xu BT,Wan SR,et al.The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction[J]. Cardiovasc Diabetol. 2023,22(01):237-244.
[7]王莹,周静威,王珍,等.糖尿病肾病中西医治疗进展[J].中国全科医学,2022,25(12):1411-1417.
[8]周淑珍,张燕媚,何志仁,等.基于中医药治疗的糖尿病肾病风险预测模型构建与验证[J].时珍国医国药,2021,32(06):1505-1509.
[9]陈占科,陈凯丽,应春苗,等.糖尿病肾脏疾病预后影响因素的COX比例风险回归模型分析[J].中华中医药学刊,2024,42(02):28-33.
[10]李京旸,张晓丽,姜敏,等.老年2型糖尿病患者25-(OH)D3、NLR、PLR与糖尿病肾病的相关性研究[J].中华中医药杂志,2023,38(07):3478-3482.
(1 摘要 Views, 2 PDF Downloads)
Refbacks
- 当前没有refback。